Aquestive Therapeutics
(NASDAQ) AQST
Aquestive Therapeutics Financials at a Glance
Market Cap
$493.06M
Revenue (TTM)
$44.55M
Net Income (TTM)
$83.78M
EPS (TTM)
$-0.78
P/E Ratio
-5.20
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$4.15
Volume
21,691
Open
$4.08
Price
$4.15
Volume
21,691
Open
$4.08
Previous Close
$4.04
Daily Range
$4.08 - $4.21
52-Week Range
$2.12 - $7.55
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$4.15
Volume
21,691
Open
$4.08
Previous Close
$4.04
Daily Range
$4.08 - $4.21
52-Week Range
$2.12 - $7.55
AQST News
AQST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aquestive Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
147
CEO
Daniel Barber, MBA
Website
www.aquestive.comHeadquarters
Warren, NJ 07059, US
AQST Financials
Key Financial Metrics (TTM)
Gross Margin
58%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
-63%
Return on Assets
-52%
Earnings Yield
-19.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$493.06M
Shares Outstanding
122.05M
Volume
21.69K
Short Interest
0.00%
Avg. Volume
4.76M
Financials (TTM)
Gross Profit
$25.99M
Operating Income
$71.05M
EBITDA
$70.49M
Operating Cash Flow
$52.43M
Capital Expenditure
$562.00K
Free Cash Flow
$52.99M
Cash & ST Invst.
$121.17M
Total Debt
$131.44M
Aquestive Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.02M
+9.7%
Gross Profit
$7.18M
-2.3%
Gross Margin
55.16%
N/A
Market Cap
$493.06M
N/A
Market Cap/Employee
$3.47M
N/A
Employees
142
N/A
Net Income
$31.86M
-86.8%
EBITDA
$28.71M
-126.1%
Quarterly Fundamentals
Net Cash
$10.28M
-130.6%
Accounts Receivable
$17.76M
+141.9%
Inventory
$6.17M
+2.1%
Long Term Debt
$119.82M
+219.8%
Short Term Debt
$11.63M
+2068.8%
Return on Assets
-52.23%
N/A
Return on Invested Capital
-62.98%
N/A
Free Cash Flow
$8.55M
-31.5%
Operating Cash Flow
$8.47M
-30.5%